High Vaccine Confidence Among Patients in Malaysia
Over the past year, biopharmaceutical companies have worked at an unprecedented speed to research and develop COVID-19 vaccines, treatments and diagnostics – supported by the innovation ecosystem along the way. As regulatory authorities continue to monitor the safety and efficacy of these innovations and authorize them for public use, it is important for patients to also feel confident in and accept inoculation once vaccine supply is available.
Intellectual Property Rights Are Vital To COVID-19 Research and Development
A recent report from the Geneva Network is highlighting the important role intellectual property (IP) has played throughout the COVID-19 pandemic, encouraging public-private partnerships, enabling global knowledge-sharing and promoting innovative collaboration.
2020 Year in Review: COVID-19 Innovation
The COVID-19 pandemic may have disrupted most aspects of life this year, but it has also spurred unprecedented innovation. Backed by strong intellectual property protections, innovative biopharmaceutical companies were able to respond to the pandemic swiftly and utilize decades of research and development efforts on viruses similar to COVID-19 to develop vaccines and therapies in record time.
ICYMI: Regional leaders commit to fostering an innovation ecosystem throughout Southeast Asia
Regional leaders recently convened for two critical meetings – the 27th annual APEC Economic Leaders’ Meeting and the ASEAN Health Summit – to discuss various economic challenges imposed by the COVID-19 pandemic and its impact on the health of patients throughout Southeast Asia.